Cargando…
Comparison of exosomes derived from induced pluripotent stem cells and mesenchymal stem cells as therapeutic nanoparticles for treatment of corneal epithelial defects
Induced pluripotent stem cells and mesenchymal stem cells are pluripotent stem cells that represent promising therapies for treating various tissue injuries and wound healing. Exosomes are nanosized extracellular vesicles that have been identified as important mediators of therapeutic functions, whi...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732275/ https://www.ncbi.nlm.nih.gov/pubmed/33049719 http://dx.doi.org/10.18632/aging.103904 |
_version_ | 1783622056882995200 |
---|---|
author | Wang, Shudan Hou, Yunlong Li, Xuran Song, Zhen Sun, Baoqi Li, Xinyue Zhang, Hong |
author_facet | Wang, Shudan Hou, Yunlong Li, Xuran Song, Zhen Sun, Baoqi Li, Xinyue Zhang, Hong |
author_sort | Wang, Shudan |
collection | PubMed |
description | Induced pluripotent stem cells and mesenchymal stem cells are pluripotent stem cells that represent promising therapies for treating various tissue injuries and wound healing. Exosomes are nanosized extracellular vesicles that have been identified as important mediators of therapeutic functions, which are performed via cell communication. In this study, we compared the efficacy of induced pluripotent stem cells-derived exosomes (iPSCs-Exos) and mesenchymal stem cells-derived exosomes (MSCs-Exos) in treating corneal epithelial defects. The characteristics of the two types of exosomes were not significantly different. Compared to MSCs-Exos, iPSCs-Exos had a better in vitro effect on the proliferation, migration, cell cycle promotion and apoptosis inhibition of human corneal epithelial cells. iPSCs/MSCs-Exos promoted cell regeneration by upregulating cyclin A and CDK2 to drive HCECs to enter the S phase from the G0/G1 phase. In vivo results from a corneal epithelial defect model showed that both iPSCs-Exos and MSCs-Exos accelerated corneal epithelium defect healing while the effects of iPSCs-Exos were much stronger than those of MSCs-Exos. This study demonstrated that iPSCs-Exos had a better therapeutic effect on corneal epithelial defect healing. Thus, a novel potential nanotherapeutic strategy for treating corneal epithelial defects and even more ocular surface disease could be undertaken by using iPSCs-Exos dissolved in eye drops. |
format | Online Article Text |
id | pubmed-7732275 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Impact Journals |
record_format | MEDLINE/PubMed |
spelling | pubmed-77322752020-12-18 Comparison of exosomes derived from induced pluripotent stem cells and mesenchymal stem cells as therapeutic nanoparticles for treatment of corneal epithelial defects Wang, Shudan Hou, Yunlong Li, Xuran Song, Zhen Sun, Baoqi Li, Xinyue Zhang, Hong Aging (Albany NY) Research Paper Induced pluripotent stem cells and mesenchymal stem cells are pluripotent stem cells that represent promising therapies for treating various tissue injuries and wound healing. Exosomes are nanosized extracellular vesicles that have been identified as important mediators of therapeutic functions, which are performed via cell communication. In this study, we compared the efficacy of induced pluripotent stem cells-derived exosomes (iPSCs-Exos) and mesenchymal stem cells-derived exosomes (MSCs-Exos) in treating corneal epithelial defects. The characteristics of the two types of exosomes were not significantly different. Compared to MSCs-Exos, iPSCs-Exos had a better in vitro effect on the proliferation, migration, cell cycle promotion and apoptosis inhibition of human corneal epithelial cells. iPSCs/MSCs-Exos promoted cell regeneration by upregulating cyclin A and CDK2 to drive HCECs to enter the S phase from the G0/G1 phase. In vivo results from a corneal epithelial defect model showed that both iPSCs-Exos and MSCs-Exos accelerated corneal epithelium defect healing while the effects of iPSCs-Exos were much stronger than those of MSCs-Exos. This study demonstrated that iPSCs-Exos had a better therapeutic effect on corneal epithelial defect healing. Thus, a novel potential nanotherapeutic strategy for treating corneal epithelial defects and even more ocular surface disease could be undertaken by using iPSCs-Exos dissolved in eye drops. Impact Journals 2020-10-13 /pmc/articles/PMC7732275/ /pubmed/33049719 http://dx.doi.org/10.18632/aging.103904 Text en Copyright: © 2020 Wang et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Paper Wang, Shudan Hou, Yunlong Li, Xuran Song, Zhen Sun, Baoqi Li, Xinyue Zhang, Hong Comparison of exosomes derived from induced pluripotent stem cells and mesenchymal stem cells as therapeutic nanoparticles for treatment of corneal epithelial defects |
title | Comparison of exosomes derived from induced pluripotent stem cells and mesenchymal stem cells as therapeutic nanoparticles for treatment of corneal epithelial defects |
title_full | Comparison of exosomes derived from induced pluripotent stem cells and mesenchymal stem cells as therapeutic nanoparticles for treatment of corneal epithelial defects |
title_fullStr | Comparison of exosomes derived from induced pluripotent stem cells and mesenchymal stem cells as therapeutic nanoparticles for treatment of corneal epithelial defects |
title_full_unstemmed | Comparison of exosomes derived from induced pluripotent stem cells and mesenchymal stem cells as therapeutic nanoparticles for treatment of corneal epithelial defects |
title_short | Comparison of exosomes derived from induced pluripotent stem cells and mesenchymal stem cells as therapeutic nanoparticles for treatment of corneal epithelial defects |
title_sort | comparison of exosomes derived from induced pluripotent stem cells and mesenchymal stem cells as therapeutic nanoparticles for treatment of corneal epithelial defects |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732275/ https://www.ncbi.nlm.nih.gov/pubmed/33049719 http://dx.doi.org/10.18632/aging.103904 |
work_keys_str_mv | AT wangshudan comparisonofexosomesderivedfrominducedpluripotentstemcellsandmesenchymalstemcellsastherapeuticnanoparticlesfortreatmentofcornealepithelialdefects AT houyunlong comparisonofexosomesderivedfrominducedpluripotentstemcellsandmesenchymalstemcellsastherapeuticnanoparticlesfortreatmentofcornealepithelialdefects AT lixuran comparisonofexosomesderivedfrominducedpluripotentstemcellsandmesenchymalstemcellsastherapeuticnanoparticlesfortreatmentofcornealepithelialdefects AT songzhen comparisonofexosomesderivedfrominducedpluripotentstemcellsandmesenchymalstemcellsastherapeuticnanoparticlesfortreatmentofcornealepithelialdefects AT sunbaoqi comparisonofexosomesderivedfrominducedpluripotentstemcellsandmesenchymalstemcellsastherapeuticnanoparticlesfortreatmentofcornealepithelialdefects AT lixinyue comparisonofexosomesderivedfrominducedpluripotentstemcellsandmesenchymalstemcellsastherapeuticnanoparticlesfortreatmentofcornealepithelialdefects AT zhanghong comparisonofexosomesderivedfrominducedpluripotentstemcellsandmesenchymalstemcellsastherapeuticnanoparticlesfortreatmentofcornealepithelialdefects |